Michael Chuong: 5-fx SMART vs 15/25-fx HART outcomes at ASTRO24

Michael Chuong shared a post on LinkedIn:

“Thanks to American Society for Radiation Oncology (ASTRO) for the invitation to share our 5-fx SMART vs 15/25-fx HART outcomes at ASTRO24.

• 211 locally advanced pancreatic cancer patients from Baptist Health Miami Cancer Institute and Memorial Sloan Kettering Cancer Center
• Ablative dose: BED10 ~100 Gy
• 2-yr LC/OS, Gr3+ tox favorable
• Online adaptive radiation therapy may offer significant benefits
• Please support our upcoming phase 3 NRG GI011 trial!”

Source: Michael Chuong/LinkedIn

More posts featuring Michael Chuong.

Michael Chuong is the GI Section Editor for the International Journal of Radiation Oncology Biology Physics. He is a Professor at Florida International University’s Herbert Wertheim College of Medicine and serves as the Vice Chair and Medical Director of the Department of Radiation Oncology at the Miami Cancer Institute.

Additionally, he is the Chief of the GI Radiation Oncology Service at Baptist Health South Florida, specializing in the treatment of gastrointestinal cancers.